- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/12 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 231/12
Total number of patents in this class: 1970
10-year publication summary
|
163
|
144
|
146
|
131
|
144
|
109
|
122
|
111
|
83
|
70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4867 |
48 |
| Bayer Cropscience AG | 2030 |
43 |
| Takeda Pharmaceutical Company Limited | 2707 |
41 |
| Epizyme, Inc. | 374 |
33 |
| Arena Pharmaceuticals, Inc. | 364 |
32 |
| Novartis AG | 10726 |
24 |
| Boehringer Ingelheim International GmbH | 4640 |
22 |
| BASF SE | 20961 |
19 |
| University of Southern California | 2112 |
19 |
| Corteva Agriscience LLC | 2691 |
18 |
| Sumitomo Chemical Company, Limited | 9051 |
17 |
| F. Hoffmann-La Roche AG | 7942 |
16 |
| Janssen Pharmaceutica N.V. | 3381 |
16 |
| E. I. du Pont de Nemours and Company | 4025 |
15 |
| Merck Patent GmbH | 5820 |
15 |
| Bayer Pharma AG | 1054 |
15 |
| Bayer Animal Health GmbH | 219 |
15 |
| The Board of Trustees of the Leland Stanford Junior University | 6447 |
14 |
| FMC Corporation | 841 |
14 |
| Merck Sharp & Dohme LLC | 3750 |
14 |
| Other owners | 1520 |